1,5ꢀDiazabicyclo[3.1.0]hexanes
Russ.Chem.Bull., Int.Ed., Vol. 52, No. 3, March, 2003
671
IR, ν/cm–1: 630, 670, 840, 950, 1020, 1220, 1250, 1440,
2890, 2940, 2990, 3110. H NMR (CDCl3), δ: 0.17 (m, 2 H,
N, 17.5. IR, ν/cm–1: 2926, 1538, 1354, 1076, 831, 747. 1H NMR
1
(DMSOꢀd6), δ: 1.95 (m, 1 H, Hax(3)); 2.00 (m, 1 H, Heq(3),
3
3
Ht(8), Ht(9), JH (8)—H (9) = 9.23 Hz); 0.23 (m, 2 H, Hc(8),
2J = –12.0 Hz); 3.10 (m, 2 H, Hax(2(4)), JH
=
(2(4))—H (3)
eq
ax
t
t
3
2
Hc(9), JH (8)—H (9) = –9.40 Hz, JH (8(9))—H (8(9)) = –4.51 Hz,
8.5 Hz); 3.53 (s, 1 H, HCring(6)); 3.61 (m, 2 H, Heq(2(4)),
2J = –12.1 Hz, 3JH
= 8.8 Hz); 7.61 (d, 1 H,
3JH (9)—H (9(8)) =c5.96 Hz, 3JH (8)—H (9) = 9.40cHz); 0.68 (m, 1 H,
c
t
(2(4))—H (3)
ax
eq
t
c
c
c
3
3
3
H(7), JH(7)—H (8(9)) = 4.82 Hz, JH(7)—H (8(9)) = 8.56 Hz); 1.50
HCAr(3)); 8.11 (d, 1 H, HCAr(4), J = 7.8 Hz); 8.15 (s, 1 H,
t
c
3
(m, 1 H, Heq(3), JH
H(6), JH(6)—H(7) = 4.87 Hz); 2.72 (m, 2 H, Heq(2), Heq(4),
= –13.16 Hz); 2.00 (d, 1 H,
HCAr(6)).
(3)—H (3)
ax
eq
3
6ꢀ(2ꢀPyridyl)ꢀ1,5ꢀdiazabicyclo[3.1.0]hexane
(1f).
3
3JH
= 8.18 Hz, JH
(3) = 11.03 Hz); 3.13
= –12.07 Hz,
eq
Found (%): N, 25.8. C9H11N3. Calculated (%): N, 26.1. IR,
ν/cm–1: 3025, 1672, 1204, 1067, 712. 1H NMR (DMSOꢀd6), δ:
1.80 (m, 2 H, Hax(3), Heq(3), 2J = –11.8 Hz); 3.08 (m,
(2(4))—H (3)
ax eq
(m, 2 H, Heq(2), Heq(4)eq, 2JH
(2(4))—H
ax
ax
(2(4))—H (2(4))
ax
3JH
= 8.92 Hz). 13C NMR (CDCl3), δ: –0.2
(2(4))—H (3)
ax
eq
3
3
(C(8), C(9)); 9.5 (C(7)); 20.6 (C(3)); 50.0 (C(2), C(4));
2 H, Hax(2(4)), JH
= 8.3 Hz, JH
=
(2(4))—H (3)
ax ax
(2(4))—H (3)
eq
ax
56.3 (C(6)).
11.1 Hz); 3.30 (s, 1 H, HCPy(6)); 3.56 (m, 2 H, Heq(2(4)),
6ꢀArylꢀ and 6ꢀheteroarylꢀ1,5ꢀdiazabicyclo[3.1.0]hexanes (1),
7ꢀarylꢀ and 7ꢀheteroarylꢀ1,6ꢀdiazabicyclo[4.1.0]heptanes (4)
(general procedure). A solution of ButOCl (0.022 mol) in MeOH
or CHCl3 (3 mL) was added dropwise with active stirring to a
solution of diaminoalkane (0.04 mol) in MeOH (30 mL) for
1b,c,e—g and 4b,e—h or in CHCl3 (30 mL) for 1d and 4c,d at
–5—0 °C. Then a solution of aldehyde (0.02 mol) in the correꢀ
sponding solvent (4—6 mL) was added. The reaction mixture
was kept for 24 h at 0—5 °C (with the use of MeOH) or at
20—25 °C (with the use of CHCl3) and filtered through a thin
layer (1.5—2.0 cm) of silica gel. The solvent was evaporated in
vacuo and water (50 mL) was added to the residue. The reaction
mixture was saturated with NaCl, extracted with ether or CH2Cl2
(3×30 mL), and dried with K2CO3. The solvent was evaporated
in vacuo and the residue was recrystallized from acetone or
ether. The spectroscopic characteristics of the compounds are
given in Table 2.
3JH
=
8.9 Hz); 7.13 (t,
1
H, HCPy(5),
= 5.3 Hz);
Py
(2(4))—H (3)
ax
eq
3
3JH(C
= 6.8 Hz, JH(C
(5))—H(C (4))
Py
(5))—H(C (6))
Py
Py
3
7.26 (d, 1 H, HCPy(3), JH(C
= 7.8 Hz); 7.58 (t,
(3))—H(C (4))
Py
Py
1 H, HCPy(4)); 8.40 (d, 1 H, HCPy(6)). 13C NMR (DMSOꢀd6),
δ: 21.50 (Cring(3)); 52.35 (Cring(2(4)); 57.39 (Cring(6)); 121.13
(CPy(3)); 123.46 (CPy(5)); 136.79 (CPy(4)); 148.52 (CPy(6));
157.07 (CPy(2)).
7ꢀPhenylꢀ1,6ꢀdiazabicyclo[4.1.0]heptane (4b). Found (%):
N, 15.6. C11H14N2. Calculated (%): N, 16.1. IR, ν/cm–1: 2938,
1
1568, 1325, 1052, 858, 745. H NMR (DMSOꢀd6), δ: 1.61 (m,
4 H, Hax(3), Heq(3), Hax(4), Heq(4)); 2.90 (m, 2 H, Hax(2),
Hax(5)); 3.30 (m, 2 H, Heq(2), Heq(5), 2JH
=
(2(5))—H (2(5))
ax
eq
–13.5 Hz); 3.79 (s, 1 H, HCring(7)); 7.30 (m, 5 H, HCAr).
13C NMR (DMSOꢀd6), δ: 7.41 (Cring(3(5))); 37.04 (Cring(2(4)));
57.71 (Cring(7)); 118.34 (CAr(2(6))); 118.75 (CAr(3(5))); 124.03
(CAr(4)); 127.19 (CAr(1)).
7ꢀ(4ꢀChlorophenyl)ꢀ1,6ꢀdiazabicyclo[4.1.0]heptane (4c).
Found (%): N, 13.0. C11H13ClN2. Calculated (%): N, 13.4. IR,
ν/cm–1: 3084, 2953, 1594, 1336, 1070, 796, 762. 1H NMR
(DMSOꢀd6), δ: 1.72 (m, 4 H, Hax(3), Heq(3), Hax(4), Heq(4));
2.88 (m, 2 H, Hax(2), Hax(5)); 3.42 (m, 2 H, Heq(2), Heq(5),
6ꢀPhenylꢀ1,5ꢀdiazabicyclo[3.1.0]hexane (1b). The IR specꢀ
trum is identical with the published data.9 1H NMR (CDCl3), δ:
2
1.90 (m, 1 H, Hax(3)); 1.95 (m, 1 H, Heq(3), J = –12.0 Hz);
3.18 (m, 2 H, Hax(2), Hax(4), 3JH
= 8.5 Hz,
(2(4))—H (4)
eq
= 11.3 Hz); 3.59 (m, 2 H, Heq(2), Heq(4),
ax
3JH
2JH
= –13.1 Hz); 3.49 (s, 1 H, HCring(7));
(2(5))—H (2(5))
ax
(2(4))—H (3)
ax
ax
eq
2J = –12.1 Hz, JH
= 1.3 Hz, JH
=
7.28 (q, 4 H, HCAr, 3J = 11.2 Hz). 13C NMR (DMSOꢀd6),
δ: 7.41 (Cring(3(5))); 37.04 (Cring(2(4))); 57.71 (Cring(7));
118.34 (CAr(3(5))); 118.75 (CAr(2(6))); 124.03 (CAr(4));
127.19 (CAr(1)).
3
3
(2(4))—H (3)
eq eq
(2(4))—H (3)
ax
eq
8.8 Hz); 3.59 (s, 1 H, HCring(6)); 7.33 (m, 5 H, HCAr). 13C NMR
(CDCl3), δ: 21.6 (Cring(3)); 52.2 (Cring(2(4))); 56.6 (Cring(6));
127.2 (CAr(2(6))); 128.16 (CAr(3(5))); 128.4 (CAr(4)); 137.0
(CAr(1)). Partial mass spectrum (EI, 70 eV), m/z (Irel (%)): 160
[M]+ (24.8), 159 [M – H]+ (100), 83 [M – Ph]+ (15), 65
[Ph]+ (28.8).
7ꢀ(4ꢀBromophenyl)ꢀ1,6ꢀdiazabicyclo[4.1.0]heptane (4d).
Found (%): N, 10.8. C11H13BrN2. Calculated (%): N, 11.1. IR,
ν/cm–1: 2914, 1585, 1340, 1105, 858, 740. 1H NMR (CDCl3), δ:
1.71 (m, 4 H, Hax(3), Heq(3), Hax(4), Heq(4)); 2.85 (m, 2 H,
Hax(2), Hax(5)); 3.40 (m, 2 H, Heq(2), Heq(5)); 3.49 (s, 1 H,
HCring(7)); 7.30 (q, 4 H, HCAr, AB system, ∆ν = 80.0, 3J =
8.2 Hz). 13C NMR (CDCl3), δ: 17.63 (Cring(3(4))); 47.31
(Cring(2(5))); 67.97 (Cring(7)); 122.45 (CAr(1)); 129.29
(CAr(3(5))); 131.49 (CAr(2(6))); 137.88 (CAr(4)).
6ꢀ(3ꢀNitrophenyl)ꢀ1,5ꢀdiazabicyclo[3.1.0]hexane (1c). The
IR spectrum is identical with the published data.9 1H NMR
(DMSOꢀd6), δ: 1.85 (m, 1 H, Hax(3)); 1.90 (m, 1 H, Heq(3),
2J = –12.2 Hz); 2.95 (m, 2 H, Hax(2), Hax(4), 3JH
=
(2(4))—H (3)
ax eq
8.4 Hz, 3JH
Heq(4), 2JH
= 11.1 Hz); 3.51 (m, 2 H, Heq(2),
(2(4))—H (3)
ax
ax
ax
= –12.3 Hz, 3JH
=
(2(4))—H (2(4))
eq
(2(4))—H (3)
eq
eq
3
1.4 Hz, JH
= 8.8 Hz); 3.59 (s, 1 H, HCring(6));
H, HCAr(6),
7ꢀ(2ꢀPyridyl)ꢀ1,6ꢀdiazabicyclo[4.1.0]heptane
(4e).
(2(4))—H (3)
ax
eq
7.61 (t,
1
H, HCAr(5)); 7.75 (d,
1
Found (%): N, 23.5. C10H13N3. Calculated (%): N, 24.0. IR,
3JH(CAr(6))—H(CAr(5)) = 7.8 Hz); 8.11 (d, 1 H, HCAr(4), 3J =
5.6 Hz); 8.15 (s, 1 H, HCAr(2)).
ν/cm–1: 1658, 1186, 1032, 710. H NMR (CDCl3), δ: 1.69 (m,
1
4 H, Hax(3), Heq(3), Hax(4), Heq(4)); 2.92 (m, 2 H, Hax(2),
6ꢀ(4ꢀChlorophenyl)ꢀ1,5ꢀdiazabicyclo[3.1.0]hexane (1d). The
IR spectrum is identical with the published data.9 1H NMR
Hax(5)); 3.45 (m, 2 H, Heq(2), Heq(5), 2JH
=
(2(5))—H (2(5))
ax
eq
–13.0 Hz); 3.78 (s, 1 H, HCring(7)); 7.13 (d, 1 H, HCPy(3), 3J =
2
3
(DMSOꢀd6), δ: 1.85 (m, 2 H, Hax(3), Heq(3), J = –12.0 Hz);
7.8 Hz); 7.25 (t, 1 H, HCPy(5), JH(C
= 6.9 Hz,
(5))—H(C (4))
Py
Py
2.91 (m, 2 H, Hax(2), Hax(4), 3J
= 8.5 Hz);
3JH(C
= 5.0 Hz); 7.68 (t, 1 H, HCPy(4)); 8.48 (d,
(5))—H(C (6))
Py
H
(2(4))—H (3)
eq
ax
Py
3.47 (m, 2 H, Heq(2), Heq(4), 2J = –12.1 Hz, 3JH
=
1 H, HCPy(6)). 13C NMR (CDCl3), δ: 17.23 (Cring(3(4))); 47.24
(Cring(2(5))); 68.82 (Cring(7)); 120.96 (CPy(3)); 123.50 (CPy(5));
136.87 (CPy(4)); 148.71 (CPy(6)); 157.59 (CPy(2)).
(2(4))—H (3)
eq
ax
8.7 Hz); 3.37 (s, 1 H, HCring(6)); 7.35 (q, 4 H, HCAr, AB
system, ∆ν = 25, 3J = 12.0 Hz).
6ꢀ(2ꢀChloroꢀ5ꢀnitrophenyl)ꢀ1,5ꢀdiazabicyclo[3.1.0]hexane
(1e). Found (%): N, 17.1. C10H10ClN3O2. Calculated (%):
7ꢀ(2ꢀFuryl)ꢀ1,6ꢀdiazabicyclo[4.1.0]heptane (4f). Found (%):
N, 16.6. C9H12N2O. Calculated (%): N, 17.1. 1H NMR